Navigation Links
CV Therapeutics Advises Stockholders to Take No Action at This Time in Response to Astellas' Tender Offer
Date:2/27/2009

re inadequately controlled or intolerant to first-line anti anginal therapies. CV Therapeutics also has other clinical and preclinical drug development candidates and programs.

Additional Information

Stockholders of CV Therapeutics are advised to read CV Therapeutics' Schedule 14D-9 statement, when it becomes available, regarding the tender offer, because it will contain important information. Stockholders may obtain a free copy of the statement at the SEC's website at www.sec.gov. Stockholders may also obtain, without charge, a copy of the statement from MacKenzie Partners, Inc., which is assisting the company, by calling 800-322-2885 toll free or by calling 212-929-5500 or by emailing cvtx@mackenziepartners.com.

Except for the historical information contained herein, the matters set forth in this press release, including statements as to research and development and commercialization of products, are forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially, including operating losses and fluctuations in operating results; capital requirements; regulatory review and approval of our products; the conduct and timing of clinical trials; commercialization of products; market acceptance of products; product labeling; concentrated customer base; reliance on strategic partnerships and collaborations; uncertainties in drug development; uncertainties regarding intellectual property and other risks detailed from time to time in CV Therapeutics' SEC reports, including its Annual Report on Form 10-K for the year ended December 3
'/>"/>

SOURCE CV Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
3. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
4. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
5. Amsterdam Molecular Therapeutics to Release H1 2007 Results on August 29, 2007
6. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
7. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
8. Cell Therapeutics, Inc. Takes Corrective Actions in Response to Nasdaq Determination
9. Amsterdam Molecular Therapeutics Reports Half Year Results 2007
10. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
11. Anesiva Grants Specific-Use License of Its Needle-Free Drug Delivery Technology to Particle Therapeutics for Diabetes Drug

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... Health care employment grew by 29,000 job...o show consistent growth during the U.S. recession...in trouble, and health systems are coming closer t...d of just administrators. , ...ment continued growing in October despite the shed...
(Date:11/24/2009)...v.24/PRNewswire-Asia/--NODPharmaceuticalsInc.annou...dthepatentapplicationfor,itsnano-particleoraldeliv...fficientapproachtoincorporatepeptidesor,proteinsin...drugs,otherwiseadministeredasinjections.NODtechnol...romoleculardrugssuchasinsulin,interferon,growthho...
(Date:11/24/2009)...v.24/PRNewswire-Asia/--ShanghaiBiolaxyannouncedthe...pprovedthe,investigationalnewdrugapplication(IND)f...informulationtotreatdiabetes.ThisIND,approvalallow..., Diabetesisadisordercharacteristicofhighbloodgl...oftenresultinseveremicro-and,macro-vasculardisease...
(Date:11/24/2009)... The FBI recently approved the Promega Power...ating in or generating DNA records for the Nationa...ison, WI USA (PRWEB) -- The FBI recently approved ...by laboratories participating in, or generating DN...). NDIS currently contains more than seven million...
Breaking Biology Technology:The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4Biolaxy Secures IND Approval for Oral Insulin 2NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2
... Ore., Dec. 18 Synthetech, Inc. (OTC,Bulletin Boa...Improvement,Awards for their outstanding accomplis...y (EHS&S) performance. The Silver Awards are prese...rs Association (SOCMA) and,sponsored by ChemStewar...y,regarded and demonstrate Synthetech,s level of c...
...OO, Mich., Dec. 18 Stryker Corporation,(NYSE: SY...on Wednesday,January 23, 2008 at 4:30 p.m., Easter... for the quarter and year ended December 31, 2007 ...ts for the quarter and year,ended December 31, 200...n P. MacMillan, President and Chief Executive Offi...
... BEACH, Calif., Dec. 18 Biomerica,Inc. (OTC Bulle...me test,for allergies to cats and announced that i... product directly to consumers through drug stores...ed under the Fortel(R) Cat,allergy test brand., A...ergic to cat dander,the most common pet allergy. C...
Other Biology Technology:Synthetech Earns National Recognition for Performance Improvement Program 2Synthetech Earns National Recognition for Performance Improvement Program 3Stryker to Host Conference Call on January 23, 2008 2Biomerica Introduces a New 15 Minute Home Test for Allergies to Cats and Receives CE Mark Approval for Home Use 2
(Date:11/24/2009)... , BATON ROUGE Antarctica has long held secret... and until recently, there has been very little in...d beneath miles of ice for millions of years. Now,...luding LSU have been funded to the tune of $10 mi...or NSF, to get to the bottom of things literally....
(Date:11/23/2009)... , Washington, D.C. The community-associated str...g bacteria resistant to most common antibioticspos...wn and is making its way into hospitals, according...ectious Diseases . , The new threat is easily p...blic places and has increased the overall burden o...
(Date:11/23/2009)... , Farmington, CT Current research suggests that... disease. The related report by Nichols et al, "U...nt a New Class of TLR2 Ligands Capable of Enhancin...e of The American Journal of Pathology . , Mult...stem attacks the brain and spinal cord, affects ne...
Breaking Biology News(10 mins):LSU gets to the bottom of things -- in Antarctica 2New study finds MRSA on the rise in hospital outpatients 2Factors from common human bacteria may trigger multiple sclerosis 2The Pittsburgh Life Sciences Greenhouse Adds Life Sciences Veterans to Executive Program 14375 1The Pittsburgh Life Sciences Greenhouse Adds Life Sciences Veterans to Executive Program 14375 2Headphones May Threaten Heart Device Performance 58972 1Headphones May Threaten Heart Device Performance 58972 2QHR Ranked 7th Largest Healthcare Management Consulting Firm in United States 58970 1QHR Ranked 7th Largest Healthcare Management Consulting Firm in United States 58970 2
...cascade of genetic reactions that allow them to su...or of Plant Cell Biology Jian-Kang Zhu has describ...es that genetic cascade. , Zhu,s findings were pub...ings of the National Academy of Sciences in a pape...onses, HOS1 is a RING E3 Ligase That Mediates the ...
...ers say exposure to a certain group of fungal spor...-can make young children more susceptible to devel...m found that infants who were exposed to basidiosp...y penicillium/aspergillus and alternaria--early in...d, pollen, dust mites, pet dander and certain food...
...ble for singing and mating are shrinking when expo...Alberta research--the first proof that natural exp... animal. , "These residues have been persisting ...bing," said Dr. Andrew Iwaniuk, a post-doctoral re...logy. "It has been years since it has been used an...
Other Biology News:Plant protection from cold decoded 2Airborne mold spores increase kids' risk for multiple allergies 2Bird brains shrink from exposure to contaminants 2
21-mer duplex from B-Bridge International
JM101 E. coli Strain from Stratagene
BD FACSAria Cell Sorting System from BD Biosciences - Immunocytometry Systems
...loping single and multi-analyte assays using Upsta...ew, improved, and user friendly IS software develo...ates for commercial or home-made multiplex kits. T...egression capabilities; the internal trouble shoot...
Biology Products: